Therapeutics and Clinical Risk Management | Volume 12 - Dove Press
IJERPH | Special Issue : Clinical Risk Management: As Modern Tool for Prevention and Management of Care and Prevention Occupational Risk
Frontiers | The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19 | Immunology
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | NEJM
Biological Risk Assessment: General Considerations for Laboratories
Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers | Haematologica
The Impact of Sickle Cell Disease: Updates in Therapeutics, Treatment, Management, and Future Directions - European Medical Journal
Therapeutics and Clinical Risk Management – ScienceOpen
Therapeutics and Clinical Risk Management – ScienceOpen
Journal of Internal Medicine - Wiley Online Library
Stages of development of gene expression-based biomarkers. In chronic... | Download Scientific Diagram
Therapeutics and Clinical Risk Management - Dove Press
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium - Annals of Oncology
Biological Risk Assessment: General Considerations for Laboratories
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review - ScienceDirect
PDF) Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor